Trials / Active Not Recruiting
Active Not RecruitingNCT06904105
A Trial of HRS-7535 Tablets in Subjects With Overweight or Obesity
A Phase 3 Clinical Study to Evaluate the Efficacy and Safety of HRS-7535 Tablets in Subjects With Overweight or Obesity
- Status
- Active Not Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 556 (actual)
- Sponsor
- Shandong Suncadia Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to evaluate the efficacy and safety of HRS-7535 in subjects with overweight or obesity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-7535 Tablets | HRS-7535 tablets. |
| DRUG | HRS-7535 Placebo Tablets | HRS-7535 placebo tablets. |
Timeline
- Start date
- 2025-04-09
- Primary completion
- 2026-05-01
- Completion
- 2026-05-01
- First posted
- 2025-04-01
- Last updated
- 2025-06-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06904105. Inclusion in this directory is not an endorsement.